In contrast, we found that tumor characteristics such as primary tumor location and phenotype had an impact on test deviations: more HER2 test deviations were seen in distal GC compared to EGJC as well as in the diffuse versus intestinal subtype according to Laurén’s classification. Here, ERBB2 is linked to neoplasm.